Macrophages Regulate Renal Fibrosis Through Modulating TGFβ Superfamily Signaling

Ma, L.J., H. Yang, A. Gaspert, G. Carlesso, M.M. Barty, J.M. Davidson, et al. 2003. Transforming growth factor-β-dependent and -independent pathways of induction of tubulointerstitial fibrosis in β6(-/-) mice. American Journal of Pathology 163: 1261–1273.

Sato, M., Y. Muragaki, S. Saika, A.B. Roberts, and A. Ooshima. 2003. Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. Journal of Clinical Investigation 112: 1486–1494.

Goto, Y., N. Manabe, K. Uchio-Yamada, M. Yamaguchi-Yamada, N. Inoue, Y. Yamamoto, et al. 2004. Augmented cytoplasmic Smad4 induces acceleration of TGF-β1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation. Cell and Tissue Research 315: 209–221.

Hwang, M., H.J. Kim, H.J. Noh, Y.C. Chang, Y.M. Chae, K.H. Kim, et al. 2006. TGF-β1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. Experimental and Molecular Pathology 81: 48–54.

Liu, F.Y., X.Z. Li, Y.M. Peng, H. Liu, and Y.H. Liu. 2007. Arkadia-Smad7-mediated positive regulation of TGF-β signaling in a rat model of tubulointerstitial fibrosis. American Journal of Nephrology 27: 176–183.

Wang, Y., Z. Zhang, H. Shen, Y. Lu, H. Li, X. Ren, et al. 2008. TGF-β1/Smad7 signaling stimulates renal tubulointerstitial fibrosis induced by AAI. Journal of Receptor and Signal Transduction Research 28: 413–428.

Tamura, M., R. Aizawa, M. Hori, and H. Ozaki. 2009. Progressive renal dysfunction and macrophage infiltration in interstitial fibrosis in an adenine-induced tubulointerstitial nephritis mouse model. Histochemistry and Cell Biology 131: 483–490.

Yeh, Y.C., W.C. Wei, Y.K. Wang, S.C. Lin, J.M. Sung, and M.J. Tang. 2010. Transforming growth factor-β1 induces Smad3-dependent β1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. American Journal of Pathology 177: 1743–1754.

Sugimoto, H., C. Yang, V.S. LeBleu, M.A. Soubasakos, M. Giraldo, M. Zeisberg, et al. 2007. BMP-7 functions as a novel hormone to facilitate liver regeneration. FASEB Journal 21: 256–264.

Zeisberg, M. 2006. Bone morphogenic protein-7 and the kidney: Current concepts and open questions. Nephrology, Dialysis, Transplantation 21: 568–573.

Zeisberg, M., J. Hanai, H. Sugimoto, T. Mammoto, D. Charytan, F. Strutz, et al. 2003. BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature Medicine 9: 964–968.

Manucha, W. 2007. Biochemical-molecular markers in unilateral ureteral obstruction. Biocell: Official Journal of the Sociedades Latinoamericanas de Microscopia Electronica et al. 31: 1–12.

Wen, J.G. 2002. Partial unilateral ureteral obstruction in rats. Neurourology and Urodynamics 21: 231–250.

Belmiro, C.L., R.G. Goncalves, E.O. Kozlowski, A.F. Werneck, C.M. Takyia, M. Leite-Jr, et al. 2011. Dermatan sulfate reduces monocyte chemoattractant protein 1 and TGF-β production, as well as macrophage recruitment and myofibroblast accumulation in mice with unilateral ureteral obstruction. Brazilian Journal of Medical and Biological Research 44: 624–633.

Sung, S.A., S.K. Jo, W.Y. Cho, N.H. Won, and H.K. Kim. 2007. Reduction of renal fibrosis as a result of liposome encapsulated clodronate induced macrophage depletion after unilateral ureteral obstruction in rats. Nephron Experimental Nephrology 105: e1–e9.

Naruse, T., Y. Yuzawa, T. Akahori, M. Mizuno, S. Maruyama, R. Kannagi, et al. 2002. P-selectin-dependent macrophage migration into the tubulointerstitium in unilateral ureteral obstruction. Kidney International 62: 94–105.

Takeda, A., A. Fukuzaki, H. Kaneto, S. Ishidoya, Y. Ogata, T. Sasaki, et al. 2000. Role of leukocyte adhesion molecules in monocyte/macrophage infiltration in weanling rats with unilateral ureteral obstruction. International Journal of Urology: Official Journal of the Japanese Urological Association 7: 415–420.

Gordon, S. 2003. Alternative activation of macrophages. Nature Reviews Immunology 3: 23–35.

Gordon, S., and F.O. Martinez. 2010. Alternative activation of macrophages: Mechanism and functions. Immunity 32: 593–604.

Geissmann, F., M.G. Manz, S. Jung, M.H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656–661.

Ricardo, S.D., H. van Goor, and A.A. Eddy. 2008. Macrophage diversity in renal injury and repair. Journal of Clinical Investigation 118: 3522–3530.

Xiao, X., I. Gaffar, P. Guo, J. Wiersch, S. Fischbach, L. Peirish, et al. 2014. M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proceedings of the National Academy of Sciences of the United States of America 111: E1211–E1220.

van Rooijen, N., J. Bakker, and A. Sanders. 1997. Transient suppression of macrophage functions by liposome-encapsulated drugs. Trends in Biotechnology 15: 178–185.

van Rooijen, N., and R. van Nieuwmegen. 1984. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. An enzyme-histochemical study. Cell and Tissue Research 238: 355–358.

Plosker, G.L., and K.L. Goa. 1994. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs 47: 945–982.

Kanis, J.A., and E.V. McCloskey. 1997. Clodronate. Cancer 80: 1691–1695.

Gewin, L., and R. Zent. 2012. How does TGF-β mediate tubulointerstitial fibrosis? Seminars in Nephrology 32: 228–235.

Wells, R.G. 2004. BMP-7: A new TGF-β family member takes the stage in colitis treatment. Inflammatory Bowel Diseases 10: 169.